| 2024 | | Serum Galectin-10: A biomarker for persistent airflow limitation in adult asthmatics | 박해심, 유민숙, 장재혁 |
| 2024 | | Contribution of non-neuronal cholinergic system to T2-low airway inflammation in severe asthma | 박해심, 장재혁 |
| 2024 | | Predicting responses to omalizumab in antihistamine-refractory chronic urticaria: A real-world longitudinal study | 남동호, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2024 | | Immune Cell-Mediated Autoimmune Responses in Severe Asthma | 박해심, 장재혁 |
| 2024 | | Diagnostic biomarkers for chronic rhinosinusitis in adult asthmatics in real-world practice | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2024 | | ST2-Mediated Neutrophilic Airway Inflammation: A Therapeutic Target for Patients With Uncontrolled Asthma | 박해심, 신유섭, 장재혁, 최영우 |
| 2024 | | Real-World Effectiveness of Statin Therapy in Adult Asthma | 박래웅, 박해심, 양형모, 이영수, 장재혁 |
| 2024 | | Contribution of monocyte and macrophage extracellular traps to neutrophilic airway inflammation in severe asthma | 박해심, 신유섭, 유민숙, 장재혁, 최영우 |
| 2023 | | Prediction of the number of asthma patients using environmental factors based on deep learning algorithms | 박해심, 장재혁 |
| 2023 | | Current Issues in the Management of IgG Subclass Deficiencies in Adults With Chronic Respiratory Diseases | 박해심, 장재혁 |
| 2023 | | Long-term efficacy of anti-IL-4 receptor antibody in a patient with aspirin-exacerbated respiratory disease and IgG4-related disease | 박해심, 이영수, 장재혁, 전현섭 |
| 2023 | | Functional Defects in B Lymphocytes in Asthmatic Patients With IgG Subclass Deficiency | 김승현, 박해심, 장재혁 |
| 2023 | | Biomarkers for predicting type 2-high and uncontrolled asthma in real-world practice | 김승현, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2022 | | Epithelial Autoantigen-Specific IgG Antibody Enhances Eosinophil Extracellular Trap Formation in Severe Asthma | 박해심, 장재혁, 최영우 |
| 2022 | | Effectiveness of Maintenance and Reliever Therapy Using Inhaled Corticosteroid–Formoterol in Asthmatics | 박래웅, 박해심, 이영수, 장재혁 |
| 2022 | | Detection of serum IgG autoantibodies to FcεRIα by ELISA in patients with chronic spontaneous urticaria | 박해심, 예영민, 유민숙, 이영수, 장재혁 |
| 2022 | | Increased serum free IgE levels in patients with chronic spontaneous urticaria (CSU) | 박해심, 예영민, 유민숙, 이영수, 장재혁 |
| 2021 | | Cefaclor-induced hypersensitivity: Differences in the incidence of anaphylaxis relative to other 2nd and 3rd generation cephalosporins | 예영민, 이영수, 장재혁 |
| 2021 | | Serum-free immunoglobulin E: A useful biomarker of atopy and type 2 asthma in adults with asthma | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2021 | | Erratum: Clustering the clinical course of chronic urticaria using a longitudinal database: Effects on urticaria remission | 남동호, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2021 | | Establishment of reference intervals of serum immunoglobulins in healthy korean adults | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2021 | | Clustering the clinical course of chronic urticaria using a longitudinal database: Effects on urticaria remission | 남동호, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2021 | | Changes in type 2 biomarkers after anti-il5 treatment in patients with severe eosinophilic asthma | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2021 | | Specific antibody deficiency in adult patients with igg or igg subclass deficiency | 박해심, 장재혁 |
| 2021 | | Recent update on the management of anaphylaxis | 박해심, 장재혁 |
| 2020 | | Pulmonary Surfactants: a New Therapeutic Target in Asthma | 박해심, 장재혁, 최영우 |
